Related Experiment Videos
Human HeLa cell enzymes that remove phosphoglycolate 3'-end groups from DNA
T A Winters1, M Weinfeld, T J Jorgensen
1Department of Radiation Medicine, Vincent T. Lombardi Cancer Research Center, Georgetown University Medical Center, Washington DC 20007.
Nucleic Acids Research
|May 25, 1992
Summary
Researchers purified human enzymes from HeLa cells that remove 3'-phosphoglycolate DNA damage. These enzymes, acting as Class II AP endonucleases, are crucial for DNA repair and distinct from bacterial enzymes like exonuclease III.
Area of Science:
- Molecular Biology
- Enzymology
- DNA Repair
Background:
- Bleomycin treatment induces DNA strand breaks with 3'-phosphoglycolate termini.
- Characterization of DNA lesions is essential for understanding repair mechanisms.
Purpose of the Study:
- To purify and characterize human enzymes capable of processing bleomycin-induced DNA damage.
- To investigate the enzymatic activities involved in removing 3'-phosphoglycolate termini.
Main Methods:
- Purification of three distinct enzyme activities from HeLa cells.
- Utilizing 32P-postlabeling assay to characterize DNA substrate.
- Assessing enzyme-dependent nucleotide incorporation and 3'-phosphoglycolate removal.
Main Results:
- Three human enzymes purified from HeLa cells convert bleomycin-treated DNA into a substrate for E. coli DNA polymerase I.
- The enzymes efficiently remove 3'-phosphoglycolate termini from DNA.
- All three enzymes exhibit Class II AP endonuclease activity.
- The enzymes lack 3' to 5' exonuclease activity.
Conclusions:
- HeLa cell enzymes play a significant role in repairing DNA damage caused by bleomycin.
- These enzymes are distinct from bacterial exonuclease III due to the absence of 3' to 5' exonuclease activity.
- The identified enzymes are crucial for DNA strand break repair pathways involving 3'-phosphoglycolate termini.